Full data view for gene TSC2

The curator’s expert opinion on the classification of a variant, can be found in the
SUMMARY record. Regarding the classification, please note that where there are several
records of the same variant, the classification of that variant may differ depending on the
submitter’s conclusion.
Information The variants shown are described using the NM_000548.3 transcript reference sequence.

8 entries on 1 page. Showing entries 1 - 8.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

P-domain     

Predict-BioInf     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
?/. 22 c.2540T>C r.(?) p.(Leu847Pro) Hamartin binding domain - Unknown - VUS g.2124385T>C g.2074384T>C - - TSC2_000466 found with 3 TSC1 variants - novel missense c.397G>A (p.Val133Ile) and 2 known variants c.965T>C and c.1335A>G; the numbering of the base position uses A in the starting ATG as +1 PubMed: Li, 2011, PubMed: Hoogeveen-Westerveld, 2012 - - De novo - - - - - DNA DHPLC Blood - TSC - PubMed: Li, 2011; PubMed: Hoogeveen-Westerveld, 2012 TS affected; sporadic case; patient has 3 TSC1 and one TSC2 variants; both clinically unaffected parents tested and TSC2 c.2540T>C not found in parents; TSC1 variant c.397G>A (p.Val133Ile) present in one of the clinically unaffected parents M - China Han - - - - 2 Rosemary Ekong
+/. 22 c.2540T>C r.(?) p.(Leu847Pro) Hamartin binding domain - Unknown - pathogenic g.2124385T>C g.2074384T>C - - TSC2_000466 pathogenicity reported as confirmed; non-conservative change originally Kwiatkowski database - - De novo - - - - - DNA ? Blood - TSC - originally Kwiatkowski database variant not seen in parents ? - - - - - - - 1 Rosemary Ekong
+/. 22 c.2540T>C r.(?) p.(Leu847Pro) Hamartin binding domain - Unknown - pathogenic g.2124385T>C g.2074384T>C - - TSC2_000466 - unpublished - - De novo - - - - - DNA SEQ Blood - TSC - unpublished 1 affected in 1 generation; parents tested and variant not found ? - - - - - - - 1 Rosemary Ekong
+/. 22 c.2540T>C r.(?) p.(Leu847Pro) Hamartin binding domain - Unknown - pathogenic g.2124385T>C g.2074384T>C - - TSC2_000466 - unpublished - - De novo - - - - - DNA SEQ Blood - TSC - unpublished 1 affected in 1 generation; parents tested and variant not found ? - - - - - - - 1 Rosemary Ekong
+/. 22 c.2540T>C r.(?) p.(Leu847Pro) Hamartin binding domain - Unknown - pathogenic g.2124385T>C g.2074384T>C - - TSC2_000466 - PubMed: Suspitsin, 2018 - - Germline - - - - - DNA SEQ-NG-I Blood - TSC MG312 PubMed: Suspitsin, 2018 19yr old index with clinical signs of TSC; variant absent in mother; DNA of father not available for testing F - Russia Slavic - - - - 1 Rosemary Ekong
+/. 22 c.2540T>C r.(?) p.(Leu847Pro) - - Maternal (confirmed) ACMG pathogenic (dominant) g.2124385T>C g.2074384T>C - - TSC2_000466 - PubMed: Ding, 2020 - - Germline - - - - - DNA SEQ - - TSC 114 PubMed: Ding, 2020 - F - China - - - - - 1 Yifeng Ding
+/. 22 c.2540T>C - p.Leu847Pro Hamartin binding domain - Unknown - NA g.2124385T>C g.2074384T>C (p.L847P) - TSC2_000466 variant inactivates the TSC complex; TSC1 and TSC2 signals significantly reduced; T389/S6K ratio significantly increased compared to wild-type TSC2; no inhibition of TORC1 Nellist, personal communication - - In vitro (cloned) - - - - - - - - - - - - - - - - - - - - - - -
+/+ 22 c.2540T>C r.(?) p.(Leu847Pro) Hamartin binding domain - Unknown - pathogenic (dominant) g.2124385T>C g.2074384T>C - - TSC2_000466 - - - - SUMMARY record - - - - - - - - - - - - - - - - - - - - - - -
Legend   How to query  

Assessment of functional consequences - Our conclusions on the functional consequences of variants are based on the type of variant, results of in vitro functional tests (doi: 10.1002/humu.21451; doi: 10.1002/humu.22202; doi: 10.1002/humu.23963), population frequencies, output from in silico splice site prediction algorithms, and any clinical/family data available to us. We also have output from protein prediction programs in this database for comparison purposes and they are not considered in our assessment of pathogenicity. PolyPhen Predictions - Note that these results are from PolyPhen-2 and only the HumDiv classification is shown.


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.